Transfuse

Transplant
To learn more or to set up a consultation Blood Bank or Molecular and
Specialty Diagnostics Business Managers, call 855.IMMUCOR (855.466.8267)
or visit www.immucor.com.
In Canada:
t 1.800.565.0653
e DBLCustomerService@immucor.com

Transform a life
Immucor, Inc. Corporate Overview

2014 Immucor, Inc. | rev. 9-2014

What We Do

History of Innovation

A leader in next-generation transfusion and transplantation

diagnostics, Immucor Inc., has been a proud partner to
thousands of hospitals, reference laboratories, and donor
centers worldwide for more than three decades. Together,
we are working to ensure that patients in need of blood,
organs, or stem cells get the right match that is safe,
accessible and affordable.

Dias
1998

Galileo
1999

ABS2000

NEO

678 placements
worldwide

2004

Rosys / ABS Precis

2007
Echo

> 500 placements

worldwide

2010

2008

2012

2013

> 1300 Echo

placements worldwide

Why It Matters

Our Mission Statement

Each year, five million people in the U.S. alone need a blood transfusion and approximately 108 million units
of blood are collected globally. According to the Global Observatory on Donation and Transplantation,
there were about 113,000 solid organ transplants in 2012 worldwide. With todays dual focus on improving
health outcomes and lowering healthcare costs, preventing negative reactions through better-matched
donations is the ultimate goal in transfusion and transplantation medicine. At Immucor, we harness the
latest breakthroughs in medical research and technology and our advanced diagnostic tools help prevent
mismatches that can cause serious, potentially life-threatening reactions. As a result of this investment,
we believe we help improve the lives of patients with better health outcomes, while potentially saving the
healthcare system millions in avoidable hospital in-patient and other medical costs associated with negative
transfusion or transplant effects.

We strive to create a world where anyone, anywhere in need of blood or an organ gets the
right blood or organ that is safe, accessible and affordable. We will be guided by our Core
Values of Respect, Integrity, Teamwork and Achievement. In doing so, we will:
strive to achieve the highest quality products and solutions;
bring forth and pursue innovations that advance patient safety
honor our customers with the highest level of service.

2014

Our Portfolio

Our Product Line

TRANSFUSION PORTFOLIO:
Serology:

Transfusion Diagnostics
Serology:

Immucor manufactures and sells a complete line of manual and automated serology typing and screening
assays used by hospitals, reference labs and donor centers to determine the best match between a patient
and donor prior to blood transfusion. We have introduced an unprecedented four generations of proprietary
blood bank automation to the market. Our automated systems feature our exclusive Capture technology
and feature the broadest test menu available as well as instant access, high throughput and fast turnaround
times. Our current instrument offering includes Echo, an instrument specially designed for small-volume
laboratories with a compact footprint; and NEO, and instrument specially designed for high-volume
laboratories with the highest throughput available in the industry.

Molecular:

Immucor is at the forefront of bringing molecular methods to the immunohematology market. Our PreciseType
HEA test is the first in a line of personalized-medicine diagnostics that uncover the specific gene variants
associated with RBC antigens to provide the closest match possible between patient and donor.

Specialty Diagnostics
Platelets:

Immucor manufactures and sells an industry-leading portfolio of

platelet assays to hospitals and reference labs to determine the best
match between a patient and donor prior to platelet transfusion. Our
complete portfolio includes products for platelet antibody screening,
platelet antibody identification and platelet crossmatching.

Coagulation:

WHO WE SERVE
Hospital Transfusion Services
Blood Donor Centers
Reference Laboratories
Transplantation Laboratories
Coagulation Laboratories

Immucor delivers a unique portfolio of products to assist with the

identification of deficiencies in clotting factors and detection of
antibodies involved in thrombosis and thrombocytopenia, providing
support for the diagnosis of Heparin-Induced Thrombocytopenia
(HIT), Von Willebrand Disease (VWD) and Thrombotic
Thrombocytopenic Purpura(TPP).

Transplant Diagnostics
Immucor manufactures and sells a complete line of assays,
marketed as LIFECODES, to hospitals and reference labs
to determine the best match between a patient and donor
prior to transplantation. Our molecular human leukocyte
antigen (HLA) typing tests and HLA antibody screening/
identification tests both run on the Luminex platform,
which has an install base of more than 1,000 instruments
worldwide in the transplantation field. Our recent acquisition
of kSORT broadens our transplant portfolio with new
assays designed to meet the increasing demand for posttransplant monitoring assays that detect graft-rejection.

NEO Blood Bank Automation

Echo Blood Bank Automation
Manual Capture Workstation
Capture Solid Phase Technology
ABO Typing Antisera
Rh and Kell Typing Antisera
Extended Phenotype Antisera
Lectins
Red Cell Antibody Screening
Red Cell Antibody Identification
Anti-Human Globulin
Potentiators/Enzymes
Direct Antiglobulin Test (DAT)
Crossmatch
CMV Antibody Screen
Syphilis Antibody Screen
Feto-Maternal Hemorrhage Screen
Complex Antibody Specialty Products
Quality Control
Competency Testing
Rh Immune Globulin

Molecular:
HEA Typing
*HPA Typing
*RhD Typing
*RhCE Typing

Data Management:
ImmuLINK

SPECIALTY PORTFOLIO:
Platelet Antibody Screening Assays
Platelet Antibody Detection Assays
Platelet Crossmatch Assay
PF4 Enhanced and IgG
vWF and Propeptide Assay
ADAMTS-13 Activity
FVIII Antibody Screening

TRANSPLANT PORTFOLIO:
Antibody Detection
HLA Genotyping
KIR Genotyping
Serologic Typing
BioMarkers

*These assays are currently

Research Use Only (RUO).

Our Global Footprint

Immucor products sold
in these countries

Global market
share leader
in transfusion
diagnostics

Immucor global offices

>95% of the North

American blood
supply screened by
Capture technology

CANADA

4 FDA licensed
manufacturing
facilities
EUROPE

JAPAN

US

Most widely
published kit for
HIT antibody
detection

Only
commercially
available kit
for VWF and
Propeptide

INDIA

Our blood bank

automation is used
by 7 of the top 10
Americas Best
Hospitals on the US
News & World Report
annual Honor Roll
>1800 blood
bank automation
placements
globally

Strategic Partnership

We partner with you to drive innovation through reagents, automation, data

management and DNA-based testing
We invest in partnership with our customers to improve their ongoing staff
education initiatives via our online education website, LEARN and through
User Group meetings
We consult with laboratories to improve their operational workflow through
value-add LEAN assessments

Our dedicated customer-facing

support groups are focused on
superior customer service:
Field Sales Team

>1000
employees
in 11
countries

Technical Specialists and Consultants

Inside Sales Team
Global Support Engineers
Technical Support and Field Service
Order Management

Most complete
platelet
compatibility
portfolio globally

>1,000,000
PreciseType tests
completed worldwide